Publications by authors named "Hemi Dimant"

Claim this Profile
C
Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.
Benjamin I Leach, Deanne Lister, Stephen R Adams, Julie Bykowski, Amy B Schwartz, Hemi Dimant

Mol Imaging Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.
Benjamin I Leach, Deanne Lister, Stephen R Adams, Julie Bykowski, Amy B Schwartz, Hemi Dimant

Mol Imaging Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers.
Benjamin I Leach, Deanne Lister, Stephen R Adams, Julie Bykowski, Amy B Schwartz, Hemi Dimant

Mol Imaging Biol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and biodistribution of under-employed gene therapy vector AAV7.
Samantha A Yost, Emre Firlar, Justin D Glenn, Hayley B Carroll, Steven Foltz, Hemi Dimant

J Virol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging.
Curt Mazur, Berit Powers, Kenneth Zasadny, Jenna M Sullivan, Hemi Dimant

JCI Insight· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of tetrafurcated dendritic units on solid support.
Adi Dahan, Hemi Dimant, Moshe Portnoy

J Comb Chem· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.
Nikolaus R McFarland, Hemi Dimant, Laura Kibuuka, Darius Ebrahimi-Fakhari, Cody A Desjardins

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics.
Hemi Dimant, Liya Zhu, Laura N Kibuuka, Zhanyun Fan, Bradley T Hyman

PLoS One· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct detection of alpha synuclein oligomers in vivo.
Hemi Dimant, Suneil K Kalia, Lorraine V Kalia, Liya N Zhu, Laura Kibuuka

Acta Neuropathol Commun· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular chaperones and co-chaperones in Parkinson disease.
Hemi Dimant, Darius Ebrahimi-Fakhari, Pamela J McLean

Neuroscientist· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells.
Hemi Dimant, Beka Solomon

Neurodegener Dis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
Sara Orgad, Hemi Dimant, Eyal Dor-On, Ronit Azriel-Rosenfeld, Itai Benhar

J Immunother· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation effect of filamentous phage on alpha-synuclein aggregation.
Hemi Dimant, Noa Sharon, Beka Solomon

Biochem Biophys Res Commun· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis